Navigation Links
Loyola researchers identify risk factor for life-threatening disease in preemies
Date:1/16/2014

Many premature infants suffer a life-threatening bowel infection called necrotizing enterocolitis (NEC).

Researchers at Loyola University Health System have identified a marker to identify those infants who are at risk for the infection, enabling doctors to employ early preventive strategies. These findings were published in the latest issue of the Journal of Pediatric Surgery.

"This information will allow us to better care for these premature infants," said Jonathan Muraskas, MD, study investigator and co-medical director of Loyola's neonatal ICU. "Simple changes to blood transfusion practices, feeding patterns and treatment of these infants may significantly reduce the incidence of NEC."

NEC is the most common serious gastrointestinal disorder among preterm newborns. It affects up to 10 percent of extremely low birth weight infants and has a mortality rate of nearly 30 percent. There is no known cause for the disease, yet researchers believe it may result from a combination of decreased blood flow to the bowel, feeding patterns, infection, mechanical injury or abnormal immune response.

NEC occurs when the lining of the intestinal wall dies and tissue falls off. Most cases of NEC are mild to moderate and can be successfully treated with antibiotics. But in severe cases, a hole can develop in the intestine, allowing bacteria to leak into the abdomen causing a life-threatening infection.

This study evaluated 177 infants born at less than 32 weeks' gestation and/or babies who were less than 3 pounds, 3 ounces. Blood samples were collected from these infants within 72 hours of birth and weekly for four weeks to measure reticulated platelets (RP) and intestinal alkaline phosphatase (iAP). Of the 177 infants, 15 (8.5 percent) developed NEC. Of these, 93 percent had low RP levels and 60 percent had high iAP. Those infants with low RP levels were significantly more likely to develop NEC while those with high iAP sh
'/>"/>

Contact: Nora Dudley
nodudley@lumc.edu
708-216-6268
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Loyola receives Innovation Award for clinical research database
2. Loyola University New Orleans’ School of Nursing is Ranked Among Best Online Nursing Programs for Third Straight Year
3. Loyola bioethics study finds medical students concerned about desensitization to dying patients
4. Loyola neurologist is co-editor of 3-volume, 1,480-page guide to clinical neurology
5. Osteoporosis drugs compared for side effects, efficacy in Loyola study
6. Risk of osteoporosis drugs side effects not significant, Loyola researchers find
7. Loyola study assesses use of fingerstick blood sample with i-STAT point-of-care device
8. Loyola University New Orleans Hosts Newly Appointed U.S. Commerce Secretary
9. Loyola School of Nursing Online DNP Program Receives Federal Grant for Health Training
10. Loyola nuclear medicine technologist named National Technologist of the Year
11. Loyola receives $1.5 million grant to study vitamin D for diabetes and depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “Wekho” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review ... locations instead of people. , An interesting new way to ... iOS and Android devices. It’s called Wekho and it’s ...
(Date:11/27/2014)... 27, 2014 This is a ... Insulin industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry covers information on policy, plans for ... structure and much more. , This ...
(Date:11/27/2014)... At The Little Gym, we know that ... no surprise when a recent study confirmed that regular ... Journal of Pediatrics found that “Promoting physical ... the school years may be important not only for ... monitored two groups of children; those that were engaging ...
(Date:11/27/2014)... November 27, 2014 The Emerald Cup ... Up-Close Look At This Year’s Entries | SKUNK Magazine ... Stay For Two At Their Resort, Pure Garden, In ... or L.A.-based Hempcon, The Emerald Cup is presented by ... draws much of California’s original cannabis industry." – SFGate, ...
(Date:11/27/2014)... 27, 2014 In addition to a ... important gift home this holiday season and become educated ... Visiting with relatives over the holidays may raise questions ... Although some change in cognitive ability can occur with ... normal aging. Recognizing the difference between normal aging and ...
Breaking Medicine News(10 mins):Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... cardiovascular disease can all cloud symptoms, study says , , WEDNESDAY, ... (MS) may be delayed in people if they have other ... high blood pressure and high cholesterol appeared to mask early ... concluded the study, published in the Oct. 29 online issue ...
... CRP may only reflect existing cardiovascular trouble, study finds ... levels of C-reactive protein do not increase the ... suggests. , The inflammation-linked molecule has gained prominence in ... But the question remained -- does the protein only ...
... Preliminary results from U.S.,Department of Defense-funded clinical trials ... rooms are contaminated with high levels of,potentially dangerous ... the Interscience Conference on Antimicrobial Agents and Chemotherapy,(ICAAC) ... that objects in,closest proximity to patients, such as ...
... 29 Texcel, a leading,provider of custom ... its innovative new StimX programmable, implantable,stimulation system., ... and development of specialty,stimulation therapies, the StimX ... platform., The StimX system,s programmable stimulation ...
... Rochester NY Growth Company, boasts premiere pharmacy services innovation. ... ... 2008 -- PharmaSmart International , an innovative health management ... levels, worksites, medical facilities and specialty care centers boasts an ...
... to the gym on a regular basis right after a ... the gym one day, then the next day and the ... that the negative effects of skipping exercise can occur in ... to a sedentary lifestyle can quickly lead to symptoms of ...
Cached Medicine News:Health News:Other Health Problems Can Delay MS Diagnosis 2Health News:Key Blood Test Protein May Not Cause Heart Disease 2Health News:Key Blood Test Protein May Not Cause Heart Disease 3Health News:First Results from Hospital Trials Show Pathogens Stay Close to Patients 2Health News:Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies 2Health News:PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services 2Health News:PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services 3Health News:PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services 4Health News:New study indicates that exercise prevents fatty liver disease 2
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
(Date:11/26/2014)... , Nov. 25, 2014 ... focused on the development of mobile diagnostic ... testing in hospital and pre-hospital settings, today ... (ISO) 13485:2003 certification.  The certification was awarded ... of the world,s leading certification bodies. ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
Breaking Medicine Technology:Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... is equipped with a new 1/2" Progressive ... excellent sensitivity (1280 (H) x 960 (V) ... uncompressed, high-resolution, digital color images and features ... an exposure range from 1/100,000 to 17.5 ...
... DP70 brings you the latest in imaging technology ... The DP70 offers high resolution, high sensitivity, and ... demanding applications, including fluorescence. CCD ... Bit Depth - 36-bit ...
4 megapixel zoom digicam with a 4x optical zoom, Effective pixels:4.0 million CCD:1/1.8-in. type (4.13 million total pixels), Max Image size:2272 (2,272 x 1,704 pixels), Lens:4x Zoom-Nikkor; f = 7.85...
... superb stand-alone digital camera with networking capability ... or remote locations. Image acquisition and camera ... operates independently or attaches directly to a ... to capture and transfer images. Sharing images ...
Medicine Products: